ANGELO CONSTANTINO: Open Payments
NPI 1669479283 · BLAWNOX, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,181 in 64 payments from 18 companies in 2025. Trend: 2023 $1,937 · 2024 $2,013 · 2025 $1,181
Food & beverage: $1,181
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $257 |
| AstraZeneca Pharmaceuticals LP | 9 | $160 |
| GlaxoSmithKline, LLC. | 6 | $137 |
| Phathom Pharmaceuticals, Inc. | 6 | $114 |
| ABBVIE INC. | 3 | $73 |
| Novo Nordisk Inc | 4 | $70 |
| Astellas Pharma US Inc | 3 | $60 |
| Lundbeck LLC | 3 | $53 |
| Lilly USA, LLC | 3 | $50 |
| PFIZER INC. | 2 | $38 |
Products named: TRELEGY ELLIPTA, OTEZLA, VOQUEZNA, TEZSPIRE, FARXIGA, AIRSUPRA, Veozah, QULIPTA.
Industry payments across PA — which companies pay providers there.
